Medical Net, Inc. (TYO:3645)

Medical Net Balance Sheet

Financials in millions JPY. Fiscal year is June - May.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 31, 2026	May 31, 2026	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022
Cash & Equivalents	1,969	1,956	1,456	1,528	1,518	1,133
Cash & Short-Term Investments	1,969	1,956	1,456	1,528	1,518	1,133
Cash Growth	27.77%	34.34%	-4.71%	0.66%	33.98%	30.53%
Receivables	885	1,048	884	834	674	649
Inventory	326	363	318	206	123	129
Other Current Assets	238	233	300	266	144	166
Total Current Assets	3,418	3,600	2,958	2,834	2,459	2,077
Property, Plant & Equipment	108	114	133	125	111	106
Long-Term Investments	297	294	195	469	497	411
Goodwill	361	376	394	446	293	462
Other Intangible Assets	39	41	34	14	12	15
Long-Term Deferred Tax Assets	114	98	75	58	49	34
Other Long-Term Assets	2	2	-	2	2	2
Total Assets	4,380	4,568	4,080	3,989	3,467	3,154

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 31, 2026	May 31, 2026	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022
Accounts Payable	399	397	408	436	322	259
Accrued Expenses	70	34	21	-	-	-
Short-Term Debt	1,085	1,086	846	530	680	630
Current Portion of Long-Term Debt	68	68	69	112	27	32
Current Income Taxes Payable	14	75	17	69	90	91
Other Current Liabilities	444	529	570	475	318	288
Total Current Liabilities	2,080	2,189	1,931	1,622	1,437	1,300
Long-Term Debt	250	267	336	387	82	111
Pension & Post-Retirement Benefits	42	44	40	40	11	5
Other Long-Term Liabilities	7	4	6	10	9	2
Total Liabilities	2,379	2,504	2,313	2,059	1,539	1,418

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 31, 2026	May 31, 2026	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022
Common Stock	286	286	286	286	286	286
Additional Paid-In Capital	348	348	337	337	337	287
Retained Earnings	1,639	1,709	1,598	1,693	1,710	1,634
Treasury Stock	-400	-400	-543	-443	-443	-511
Comprehensive Income & Other	47	50	37	33	26	11
Total Common Equity	1,920	1,993	1,715	1,906	1,916	1,707
Minority Interest	81	71	52	24	12	29
Shareholders' Equity	2,001	2,064	1,767	1,930	1,928	1,736
Total Liabilities & Equity	4,380	4,568	4,080	3,989	3,467	3,154

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 31, 2026	May 31, 2026	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022
Total Debt	1,403	1,421	1,251	1,029	789	773
Net Cash (Debt)	566	535	205	499	729	360
Net Cash Growth	74.69%	160.98%	-58.92%	-31.55%	102.50%	-25.93%
Net Cash Per Share	61.25	58.22	22.97	55.17	81.35	41.14
Filing Date Shares Outstanding	9.17	9.25	9.27	9.05	9.05	8.82
Total Common Shares Outstanding	9.17	9.25	8.73	9.05	9.05	8.82
Working Capital	1,338	1,411	1,027	1,212	1,022	777
Book Value Per Share	209.26	215.53	196.41	210.72	211.82	193.63
Tangible Book Value	1,520	1,576	1,287	1,446	1,611	1,230
Tangible Book Value Per Share	165.67	170.43	147.39	159.86	178.10	139.52

Data Source: S&P Global Market Intelligence Last updated: Oct 15, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 31, 2026

Data Sources Report a data error